Results 21 to 30 of about 919 (164)

Intravitreal Injections in Arc Sterile Setting: Safety Profile after More Than 10,000 Treatments

Journal of Ophthalmology, 2020
Purpose. To report the occurrence of endophthalmitis and other complications after intravitreal injections (IVIs) in the Arc Sterile setting. Methods.
Claudio Furino, Maria Oliva Grassi, Vito Bini, Annalisa Nacucchi, Francesco Boscia, Michele Reibaldi, Nicola Recchimurzo, Giovanni Alessio   +7 more
doaj   +2 more sources

Ocriplasmin: who is the best candidate?

Clinical Ophthalmology, 2016
Claudia M Prospero Ponce, William Stevenson, Rachel Gelman, Daniel R Agarwal, John B Christoforidis Retina Division, Department of Ophthalmology, University of Arizona Medical Center, Tucson, AZ, USA Abstract: Enzymatic vitreolysis is currently the ...
Prospero Ponce CM, Stevenson W, Gelman R, Agarwal DR, Christoforidis JB   +4 more
doaj   +1 more source

Retinal breaks due to intravitreal ocriplasmin

Clinical Ophthalmology, 2014
Ruwan A Silva, Darius M Moshfeghi, Theodore Leng Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, CA, USA Abstract: Ocriplasmin represents a new treatment option for numerous vitreoretinopathies involving an abnormal ...
Silva RA, Moshfeghi DM, Leng T
doaj   +1 more source

Pathogenesis and Management of Macular Hole: Review of Current Advances

Journal of Ophthalmology, 2019
Macular hole has been believed to be a disorder of vitreomacular interface, which forms as a result of abnormal vitreous traction from incomplete vitreous detachment.
Guzel Bikbova, Toshiyuki Oshitari, Takayuki Baba, Shuichi Yamamoto, Keisuke Mori   +4 more
doaj   +2 more sources

Identification of novel gene signatures and immune cell infiltration in intervertebral disc degeneration using bioinformatics analysis [PDF]

Frontiers in Molecular Biosciences, 2023
Background: Intervertebral disc degeneration (IDD) is the leading cause of lower back pain, and an overall understanding of the molecular mechanisms related to IDD is still lacking. The purpose of this study was to explore gene signatures and immune cell
Tao Tang, Tao Tang, Zhongyuan He, Zhongyuan He, Zhengya Zhu, Fuan Wang, Fuan Wang, Hongkun Chen, Fu Zhang, Jiaxiang Zhou, Jianmin Wang, Baoliang Li, Baoliang Li, Xizhe Liu, Zhiyu Zhou, Zhiyu Zhou, Shaoyu Liu, Shaoyu Liu   +17 more
doaj   +2 more sources

Transient visual loss and delayed resolution of vitreomacular traction after intravitreal ocriplasmin

Drug, Healthcare and Patient Safety, 2014
Joanna DaCosta,1,2 Saad Younis1 1The Western Eye Hospital, Imperial College Healthcare National Health Service Trust, London, United Kingdom; 2Barts Health National Health Service Trust, St Bartholomew's Hospital, West Smithfield, London, United ...
DaCosta J, Younis S
doaj   +1 more source

Unraveling the molecular landscape of pancreatic cancer: a systems biology approach to identify therapeutic targets [PDF]

Discover Oncology
Background Due to late diagnosis and limited treatment options for pancreatic ductal adenocarcinoma (PDAC), identifying novel therapeutic targets is crucial to improving patient outcomes.
Elham Ahmadipour, Sepideh Ebrahimi, Hamid Nasri, Forouzan Amerizadeh   +3 more
doaj   +2 more sources

Ocriplasmin for symptomatic vitreomacular adhesion [PDF]

Cochrane Database of Systematic Reviews, 2017
Symptomatic vitreomacular adhesion (sVMA) is a recognised cause of visual loss and by tradition has been managed by pars plana vitrectomy (PPV). A less invasive alternative to surgery in some people is enzymatic vitreolysis, using an intravitreal injection of ocriplasmin.To assess the efficacy and safety of ocriplasmin compared to no treatment, sham or
Neffendorf, James E, Kirthi, Varo, Pringle, Edward, Jackson, Timothy L   +3 more
openaire   +6 more sources

Identification of potential biomarkers for atrial fibrillation and stable coronary artery disease based on WGCNA and machine algorithms [PDF]

BMC Cardiovascular Disorders
Background Patients with atrial fibrillation (AF) often have coronary artery disease (CAD), but the biological link between them remains unclear. This study aims to explore the common pathogenesis of AF and CAD and identify common biomarkers.
Ke Wu, Hao Chen, Fan Li, Xiangjuan Meng, Lin Chen, Nannan Li   +5 more
doaj   +2 more sources

The Inflation Reduction Act: A boon for the generic and biosimilar industry

Journal of Clinical Pharmacy and Therapeutics, Volume 47, Issue 11, Page 1738-1751, November 2022., 2022
The Inflation Reduction Act gives a significant boost to generics and biosimilars!Soon lowered out‐of‐pocket costBiosimilars promoted and adopted Abstract What is Known and Objective After more than a year of negotiation, a $740 billion climate and health care bill known as The Inflation Reduction Act (IRA) became law on 16 August 2022.
Sarfaraz K. Niazi
wiley   +1 more source